Barinthus Biotherapeutics Plc (BRNS)
0.7401
-0.02
(-2.49%)
USD |
NASDAQ |
Sep 08, 16:00
0.7628
+0.02
(+3.07%)
After-Hours: 20:00
Barinthus Biotherapeutics Total Assets (Quarterly) : 81.89M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 81.89M |
| March 31, 2026 | 92.14M |
| December 31, 2025 | 105.38M |
| September 30, 2025 | 109.20M |
| June 30, 2025 | 129.56M |
| March 31, 2025 | 142.00M |
| December 31, 2024 | 170.14M |
| September 30, 2024 | 188.69M |
| June 30, 2024 | 186.75M |
| March 31, 2024 | 199.48M |
| December 31, 2023 | 225.68M |
| Date | Value |
|---|---|
| September 30, 2023 | 229.97M |
| June 30, 2023 | 246.13M |
| March 31, 2023 | 261.82M |
| December 31, 2022 | 279.14M |
| September 30, 2022 | 275.48M |
| June 30, 2022 | 285.06M |
| March 31, 2022 | 286.12M |
| December 31, 2021 | |
| September 30, 2021 | 256.57M |
| June 30, 2021 | 259.84M |
| March 31, 2021 | 166.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 896.11M |
| Autolus Therapeutics Plc | 493.23M |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Adaptimmune Therapeutics Plc | 130.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.76M |
| Shareholders Equity (Quarterly) | 57.07M |
| Debt to Equity Ratio | 0.1804 |
| Current Ratio | 5.539 |
| Net Debt Paydown Yield | 1.20% |